ANTITHROMBOTIC ACTIVITY OF SBT-828 COMPOUND

ANTITHROMBOTIC ACTIVITY OF SBT-828 COMPOUND

We have studied antiplatelet activity of new indole derivants on the experimental model of ADP induced aggregation of platelets in rabbit's plasma in vitro. Seven of the studied substances exceeded comparing drug of acetylsalicylic acid on EK50

Bibliographic Details
Main Authors:	V. S. Sirotenko, M. Туan
Format:	Article
Language:	Russian
Published:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2015-09-01
Series:	Фармация и фармакология (Пятигорск)
Subjects:	indole antiaggregation activity acetylsalicylic acid
Online Access:	https://www.pharmpharm.ru/jour/article/view/129

Similar Items

ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
by: N. A. Dmitrieva, et al.
Published: (2016-01-01)

ACETYLSALICYLIC ACID AND PREVENTION OF FATAL OUTCOMES IN CARDIOVASCULAR DISEASE: SELECTING MEDICATION FORM AND DOSE
by: O. V. Averkov
Published: (2012-08-01)

Clinical pharmacogenetics of antiaggregants: clinical pharmacologist' point of view
by: D. A. Syche, et al.
Published: (2007-08-01)

Antiaggregants in cardiology: choice of best individual treatment
by: A. N. Yakovlev
Published: (2015-12-01)

Zyllt in coronary atherosclerosis patients after coronary artery bypass graft surgery. Preliminary results of an open, randomized, comparative ZEUS Study
by: Y. I. Grinstein, et al.
Published: (2008-12-01)

ANALYSIS OF OUTPATIENT PHYSICIANS, PRESCRIPTION OF DISAGGREGANT THERAPY FOR PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION AND/OR CORONARY ANGIOPLASTY WITH STENT IMPLANTATION WITHIN THE RECVAD REGISTRY
by: A. V. Zagrebelnyi, et al.
Published: (2015-10-01)

IN VITRO EVALUATION OF ANTITHROMBOTIC AND ANTICOAGULANT ACTIVITY OF HERBAL SOURCES
by: G.M. ABDULLINA, et al.
Published: (2024-03-01)

THE SELECTION PROBLEMS OF ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION WITH COMORBIDITIES
by: N. A. Koziolova, et al.
Published: (2015-08-01)

A Rational Approach to a De-Escalation of Double Antithrombotic Therapy: The Possibilities of Clopidogrel
by: V. V. Kashtalap, et al.
Published: (2019-10-01)

Empleo de fármacos antitrombóticos Use of antithrombotic drugs
by: Alejandro R. Pérez Valdés, et al.
Published: (2007-12-01)

Association of Prior Antithrombotic Drug Use with 90-Day Mortality After Intracerebral Hemorrhage
by: Jørgensen CM, et al.
Published: (2024-12-01)

ANTIAGGREGANT ACTIVITY OF THE ETHANOLIC EXTRACTS OF <I>Solanum tuberosum</I> IN HUMAN PLATELETS
by: Diana M. BUITRAGO R., et al.
Published: (2009-02-01)

Antithrombotic therapy in COVID-19 patients
by: E. V. Slukhanchuk, et al.
Published: (2023-01-01)

Results of Preclinical Studies of 4-(2-(4-nitrophenyl)-2-oxoethyl)-1-(thietane-3-yl)-1H-1,2,4-triazole-4-th Bromide in Relation to the Hemostasis System <i>in vivo</i>
by: Y. Wang, et al.
Published: (2024-03-01)

PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE?
by: I. V. Zotova, et al.
Published: (2016-01-01)

Thioterpenoids as Potential Antithrombotic Drugs: Molecular Docking, Antiaggregant, Anticoagulant and Antioxidant Activities
by: Alexander A. Ksenofontov, et al.
Published: (2022-10-01)

HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS?
by: E. P. PANCHENKO
Published: (2017-12-01)

PLATELET ANTIAGGREGANTS: MECHANISMS OF ACTION AND USE ASOCIED RISKS
by: Iván F. PALOMO G, et al.
Published: (2009-05-01)

SOME ASPECTS OF IMPROVING ADHERENCE TO DUAL ANTITHROMBOTIC THERAPY AFTER ACUTE CORONARY SYNDROME
by: A. D. Erlikh
Published: (2017-05-01)

Chemoreactome analysis of the antithrombotic effects of glucosamine sulfate and nonsteroidal anti-inflammatory drugs
by: O. A. Gromova, et al.
Published: (2019-03-01)

Clopidogrel in cardiovascular disease treatment: modern clinical recommendations
by: I. S. Yavelov
Published: (2006-10-01)

Synthesis and biological evaluation of novel β-cyclodextrin-fluvastatin conjugates
by: Mariacristina Nicolosi, et al.
Published: (2021-01-01)

Acetylsalicylic acid (ASA) as inductor of growth and flowering in tomato
by: Artur Ascanio Almeida Barroso, et al.
Published: (2022-04-01)

Preparation and activity of glycosylated acetylsalicylic acid
by: Gangliang Huang, et al.
Published: (2018-02-01)

Synthesis and Anticancer Activity Evaluation of Hydrolyzed Derivatives of <i>Panaxnotoginseng</i> Saponins
by: Lei Xu, et al.
Published: (2018-11-01)

Acetylsalicylic acid in the prevention and treatment of ischemic stroke
by: A. V. Fonyakin
Published: (2010-06-01)

Acetylsalicylic acid as the only pharmacological method for the prevention of preeclampsia: A retrospective study
by: Olga M. Kravtsova, et al.
Published: (2023-07-01)

CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES
by: P. J. Dovgalevsky, et al.
Published: (2016-01-01)

Clinical evidences of low-dose rivaroxaban + acetylsalicylic acid treatment – who should be treated with dual pathway antithrombotic therapy?
by: Zoltán Járai
Published: (2024-04-01)

To continue or discontinue aspirin? The risk of perioperative complications
by: Anna Mroczek, et al.
Published: (2018-08-01)

To continue or discontinue aspirin? The risk of perioperative complications
by: Anna Mroczek, et al.
Published: (2018-08-01)

New data on the use of rosuvastatin and acetylsalicyl acid for the prolongation of human life
by: M. V. Ezhov, et al.
Published: (2018-04-01)

Antithrombotic effect of different acetylsalicylic acid drug formulations: is there a difference?
by: A. V. Sidorov
Published: (2021-11-01)

Clinical pharmacology of acetylsalicylic acid as an anti-thrombotic agent
by: V. V. Rafalsky, et al.
Published: (1970-01-01)

COMBINED ACETYLSALICYLIC ACID TABLETS TECHNOLOGY
by: A. V. Simonyan, et al.
Published: (2019-01-01)

Algorithm for antithrombotic therapy in patients with ischemic stroke after thrombolysis
by: MA Domashenko, et al.
Published: (2014-12-01)

LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS?
by: I. V. Zhirov
Published: (2016-01-01)

ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID
by: I. N. Bokarev, et al.
Published: (2016-01-01)

ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS
by: A. V. Govorin, et al.
Published: (2015-12-01)

SYNTHESIS, ANTIAGGREGATION AND ANTITROMBOTIC ACTIVITIES OF NEW DERIVATIVES OF HYDROXYBENZOIC ACIDS WITH TAURIC FRAGMENT
by: A. K. Brel, et al.
Published: (2021-08-01)